Introduction {#section1-1534735417753540}
============

Combined modality therapy is used in the treatment of the majority of patients with locally advanced head and neck cancer (HNC).^[@bibr1-1534735417753540],[@bibr2-1534735417753540]^ Unfortunately, these treatment regimens result in substantial acute and late effects.^[@bibr3-1534735417753540],[@bibr4-1534735417753540]^ While many acute toxicities subside on completion of cancer therapy, HNC survivors frequently experience late effects that result in symptom burden, functional deficits, and decreased quality of life (QOL).^[@bibr1-1534735417753540],[@bibr2-1534735417753540],[@bibr5-1534735417753540]^ Musculoskeletal impairment (MSI) is a critical yet under reported and understudied complication of HNC therapy. It is most commonly manifested as soft tissue damage and dysfunction involving the jaw, neck, shoulders, and chest. Although soft tissue damage due to cancer and surgery have long been known to cause MSI, the critical role of lymphedema and fibrosis are just now being appreciated. Regardless of cause, MSI results in a myriad of problems, including pain, postural abnormalities,^[@bibr6-1534735417753540]^ and loss of critical functions such as jaw or neck range of motion (ROM).^[@bibr7-1534735417753540]^ Furthermore, MSI may also contribute to psychological distress (eg, anxiety, body image disturbance),^[@bibr8-1534735417753540],[@bibr9-1534735417753540]^ increased health care expenses,^[@bibr10-1534735417753540]^ and loss of work.^[@bibr11-1534735417753540]^ MSI itself may be exacerbated by muscular tension and fear of movement resulting from states of high anxiety and distress. The clinically observed consequence is a self-perpetuating spiral that results in worsening functional loss and increasing symptom burden over time.^[@bibr12-1534735417753540],[@bibr13-1534735417753540]^

Yoga has been used to treat diseases in contemporary Western society with increasing frequency since the late 1970s.^[@bibr14-1534735417753540]^ Yoga is often used as a reasonably safe complementary modality for health maintenance and restoration, as well as an adjunct tool in the chronically ill.^[@bibr15-1534735417753540][@bibr16-1534735417753540][@bibr17-1534735417753540][@bibr18-1534735417753540][@bibr19-1534735417753540][@bibr20-1534735417753540][@bibr21-1534735417753540][@bibr22-1534735417753540]-[@bibr23-1534735417753540]^ In cancer patients, the vast majority of yoga studies have been conducted in survivors of breast cancer.^[@bibr24-1534735417753540][@bibr25-1534735417753540]-[@bibr26-1534735417753540]^ Studies suggest that yoga is an effective intervention for managing cancer-related symptoms, ameliorating psychosocial distress, and enhancing overall QOL.^[@bibr15-1534735417753540][@bibr16-1534735417753540][@bibr17-1534735417753540][@bibr18-1534735417753540][@bibr19-1534735417753540][@bibr20-1534735417753540][@bibr21-1534735417753540][@bibr22-1534735417753540][@bibr23-1534735417753540][@bibr24-1534735417753540][@bibr25-1534735417753540][@bibr26-1534735417753540]-[@bibr27-1534735417753540]^ Key components of a yoga practice include: postures, breathing practice, relaxation techniques, and meditation.^[@bibr28-1534735417753540]^

Specifically, a growing body of literature supports the positive impact of yoga in reducing stress and improving systemic symptoms such as pain,^[@bibr29-1534735417753540]^ fatigue,^[@bibr30-1534735417753540]^ anxiety,^[@bibr31-1534735417753540]^ depression,^[@bibr32-1534735417753540]^ and insomnia.^[@bibr33-1534735417753540]^ In addition, through the practice of asanas, yoga may improve physical functionion.^[@bibr34-1534735417753540]^

The conceptual framework that guided the study was based on the assumption that yoga has the potential to improve MSI by addressing physical limitations, through the postures that improve ROM and lymph flow. It may decrease anxiety, fear, and muscle tension through meditation, awareness practice, and breathe work. Yoga may address the key factors that contribute to worsening MSI, potentially breaking the cycle that leads to deteriorating function over time. Studies exploring the feasibility, safety, and efficacy of hatha yoga HNC patients are lacking. We conducted a pilot study in HNC survivors to determine the following: (1) manifested physical impairments, (2) need for modified yoga postures, (3) feasibility of using a tailored hatha yoga program in the population, and (4) potential efficacy. In this article, we report on feasibility and preliminary efficacy outcomes.

Patients and Methods {#section2-1534735417753540}
====================

This study used a wait-list control design. Consented patients were randomly assigned either to an 8-week yoga intervention group or to a wait-list group that completed study visits and was then offered the same yoga practice that the intervention group received. Approval for this study was obtained from the Vanderbilt-Ingram Cancer Center Scientific Review Committee, Nashville, Tennessee, USA under the Vanderbilt Institutional Review Board approval number 121357. The study was conducted at the Vanderbilt University School of Nursing.

Recruitment took place from October 2013 until July 2015. Inclusion criteria were (1) ≥18 years old, (2) \>3 months post HNC treatment, (3) no active cancer, (4) English speaking, (5) willing/able to conduct home practice and drive to the study site, (6) passing screening tool questions that included the Short Portable Mental Status Questionnaire, (7) completed medically indicated physical therapy, and (8) medical clearance. Exclusion criteria included (1) a prior cancer diagnosis ≤past 3 years, other than HNC; (2) previous radiation therapy or chemotherapy for other type of cancer; (3) medical conditions prohibiting safe implementation of yoga (eg, vertigo, suicidal ideations); or (4) active yoga practice of any frequency ≤past 6 months. Participants received compensation of \$110.

Data Collection {#section3-1534735417753540}
---------------

### Feasibility Measures {#section4-1534735417753540}

Feasibility data were collected as follows:

1.  *Recruitment Log*: Number screened, eligible, interested, not interested, and enrolled.

2.  *Participant Practice Log*: Patients completed a self-reported home yoga practice log.

3.  *Guided Yoga Sessions Log*: The yoga instructor recorded guided practice attendance and reasons for missed sessions.

4.  *Fidelity*: The consultants reviewed 10% of the videotaped sessions.^[@bibr35-1534735417753540]^

5.  *Common Terminology Criteria for Adverse Events (CTCAE Criteria version 4.0)*: Adverse events were evaluated using the CTCAE grading (severity) scale.^[@bibr36-1534735417753540]^

6.  *Columbia Suicide Severity Rating Scale(C-SSRS)*: Trained staff administered this instrument.^[@bibr37-1534735417753540]^ A positive score required patient assessment.

7.  *Satisfaction Questionnaire Form*: Patients completed a 9-question self-report rating scale with anchors of 0 totally unsatisfied to 10 highly satisfied with the yoga program, practice log, and yoga booklet.

### Efficacy Measures {#section5-1534735417753540}

Physical and emotional outcomes were assessed by trained staff at baseline, 4 weeks, and 8 weeks as follows:

1.  *Maximal interincisal opening (MIO), cervical range of motion (CROM), shoulder range of motion (SROM)*: Standard devices were used to obtain these measurements.^[@bibr38-1534735417753540][@bibr39-1534735417753540][@bibr40-1534735417753540]-[@bibr41-1534735417753540]^

2.  *Posture assessment*: Spinal deviation from proper alignment by use of photography against a grid and computer analysis of the body.^[@bibr42-1534735417753540]^

3.  *The Vanderbilt Head and Neck Symptom Survey (VHNSS--Version 2)*: This self-report validated measure assessed symptom burden.^[@bibr43-1534735417753540],[@bibr44-1534735417753540]^

4.  *Brief Pain Inventory--Short Form (BPI-SF)*: This self-reported survey captured participant's pain experience.^[@bibr45-1534735417753540]^

5.  *Hospital Anxiety and Depression Scale (HADS)*: This self-report survey measured anxiety and depression.^[@bibr46-1534735417753540],[@bibr47-1534735417753540]^ The medical oncologist was notified if a participant scored 8 or higher on either scale.

6.  *Body Image Quality Life Instrument (BIQLI)*: Participants completed a self-report scale ranging from very negative (−3) to very positive (+3) effects of body image on 19 life domains.^[@bibr48-1534735417753540],[@bibr49-1534735417753540]^

Procedures {#section6-1534735417753540}
----------

Baseline study measures were obtained. Participants were then randomized via a computer generated, permuted block program, to either an initial yoga evaluation and intervention group, or to a wait-list control group.

Intervention {#section7-1534735417753540}
------------

The protocol addressed all traditional hatha yoga practice components: postures, breathing, relaxation techniques, and meditation. Sixteen core poses were chosen to comprise the head and neck yoga toolbox; these poses were selected because they involved structures critical for optimizing mobility or strength in the neck and shoulders. Participants were given a booklet and the Toolbox, which described the postures, awareness practice, breathing practice, relaxation practice and meditation.

### Intervention Group {#section8-1534735417753540}

Prior to initiating the intervention, a comprehensive evaluation was undertaken by the yoga instructor. Evaluation included an assessment of the physical, mental, and psychological limitations with emphasis on jaw, neck, and shoulder dysfunction. The core 16 poses were modified as deemed necessary by the instructor based on this assessment so that they were safe and feasible for the patient to perform and medical approval was obtained for this practice plan. Limitations were discussed with the participant. The practice plan was revised at weeks 3 or 4, or when modifications were indicated. Participants underwent tailored yoga sessions 3 times a week for 4 weeks then 2 times a week for 4 weeks with home practice on all other days. Guided sessions were videotaped. The initial session began with education regarding yoga principles, practice guidelines, and safety. Participants were then guided to observe their physical, psychological, and energy states, in order to enhance self-awareness.^[@bibr28-1534735417753540]^ Participants with lower extremity or pelvic weaknesses initially used a chair for support. As strength improved, they graduated to a standing or a floor pose. Throughout the practice, emphasis was placed on proper alignment and recognition of physical limitations in order to avoid injury. For participants with severe trunk weakness, props (eg, a slightly reclining hard backed chair, pillows, and supports) were used to ensure spinal alignment.

Participants were taught breath awareness, diaphragmatic, thoracic, clavicular breathing, and the complete yoga breath.^[@bibr28-1534735417753540]^ Participants were instructed on tension/systematic relaxation and *yoga nidra* techniques, including guided imagery.^[@bibr28-1534735417753540]^ Sessions ended with meditation with either chanting a mantra silently or inner silence.

At the start of all subsequent guided sessions, participants were queried about any concerns or yoga related adverse events. Sessions lasted 30 minutes for participants with significant limitations with gradual increase to no more than 90 minutes as physical and mental endurance improved. Physical and psychological limitations and barriers were documented. Personal daily home practice was encouraged.

### Wait-List Control Group {#section9-1534735417753540}

Participants in the wait-list control group completed the baseline, 4-week, and 8-week follow-up assessments. They were then offered the tailored yoga program.

Statistical Analysis {#section10-1534735417753540}
--------------------

Frequency distributions were used to summarize the nominal and ordinal categorical data. Normally distributed continuous data were summarized using mean and standard deviation. However, most of the continuous distributions were skewed. Those were summarized using median and interquartile range (IQR). Comparisons of the demographic and clinical characteristics of the study groups were conducted using chi-square tests of independence (nominal, ordinal data) and Mann-Whitney tests (continuous data). Mixed-level generalized linear modeling with the log-link function was used to assess differences in the patterns of change in the study outcome variables between the two groups. The key effect of interest in these analyses was the interaction effect of group and time of assessment. This effect would indicate that the pattern of change in the intervention group was different from that observed in the control group over the same time period. Cohen's *d* effect index was generated for all findings. While this index was the most important statistic used in evaluating the effects of yoga in this preliminary study, a maximum alpha of .05 (*P* \< .05) was used for conclusions of statistical significance.

Results {#section11-1534735417753540}
=======

Participant Characteristics {#section12-1534735417753540}
---------------------------

The study consisted primarily of older, white males living in rural/suburban areas. Summaries of the demographic and disease/treatment, characteristics of the 35 patients who participated in the study (intervention group n = 15, control group n = 20) are shown in [Table 1](#table1-1534735417753540){ref-type="table"}. Fifty-seven percent (24 of 35) had been diagnosed with oropharynx cancer and approximately 74% had stage IV disease, 20% (7 of 35) had a tracheotomy and 17.1% (6 of 35) had a feeding tube during the study.

###### 

Demographic and Clinical Characteristics by Study Group (N = 35).

![](10.1177_1534735417753540-table1)

  Characteristic                                                        Overall (N = 35)   Intervention (n = 15)   Control (n = 20)   *P*
  --------------------------------------------------------------------- ------------------ ----------------------- ------------------ ------
  Age, y, mean (SD)                                                     63.2 (8.5)         65.0 (7.4)              61.8 (9.2)         .268
  Years of education, mean (SD)                                         14.4 (2.8)         15.1 (3.0)              13.8 (2.5)         .163
  Gender, n (%)                                                                                                                       .267
   Female                                                               13 (37.1)          4 (26.7)                9 (45.0)           
   Male                                                                 22 (62.9)          11 (73.3)               11 (55.0)          
  Race, n (%)                                                                                                                         .265
   Black or African American or Asian                                   5 (14.3)           1 (6.7)                 4 (20.0)           
   White                                                                30 (85.7)          14 (93.3)               16 (80.0)          
  Marital status, n (%)                                                                                                               .486
   Single/Widowed/Other                                                 14 (40.0)          7 (46.7)                7 (35.0)           
   Married/Partnered                                                    21 (60.0)          8 (53.3)                13 (65.0)          
  Employment, n (%)                                                                                                                   .503
   Employed                                                             15 (42.9)          5 (33.3)                10 (50.0)          
   Not employed                                                         17 (48.6)          9 (60.0)                8 (40.0)           
   Other                                                                3 (8.6)            1 (6.7)                 2 (10.0)           
  Income, \$, n (%)                                                                                                                   .534
   ≤30 000                                                              11 (31.4)          5 (33.3)                6 (30.0)           
   \>30 000                                                             19 (54.3)          9 (60.0)                10 (50.0)          
   Don't care to respond                                                5 (14.3)           1 (6.7)                 4 (20.0)           
  Residence, n (%)                                                                                                                    .486
   Urban                                                                14 (40.0)          7 (46.7)                7 (35.0)           
   Rural/Suburban                                                       21 (60.0)          8 (53.3)                13 (65.0)          
  Time since diagnosis, mo, median \[IQR\]                              35.7 \[9-63\]      45.7 \[9-63\]           28.4 \[10-67\]     .764
  Time since last treatment, mo, median \[IQR\]                         19.8 \[4-52\]      43.3 \[5-59\]           17.0 \[3-43\]      .286
  Location of primary lesion, n (%)                                                                                                   .564
   Oral cavity                                                          7 (20.0)           2 (13.3)                5 (25.0)           
   Oropharynx                                                           20 (57.1)          10 (66.7)               10 (50.0)          
   Larynx                                                               4 (11.4)           1 (6.7)                 3 (15.0)           
   Salivary gland                                                       3 (8.6)            2 (13.3)                1 (5.0)            
   Other                                                                1 (2.9)            0 (0.0)                 1 (5.0)            
  Stage,^[a](#table-fn2-1534735417753540){ref-type="table-fn"}^ n (%)                                                                 .235
   I-II                                                                 2 (5.9)            0 (0.0)                 2 (10.5)           
   III                                                                  7 (20.6)           2 (13.3)                5 (26.3)           
   IV                                                                   25 (73.5)          13 (86.7)               12 (63.2)          
  Tumor-expressed virus, n (%)                                                                                                        .994
   None                                                                 7 (20.0)           3 (20.0)                4 (20.0)           
   Human papilloma virus                                                12 (34.3)          5 (33.3)                7 (35.0)           
   Not tested                                                           16 (45.7)          7 (46.7)                9 (45.0)           
  Total treatment received, n (%)                                                                                                     .744
   Surgery only                                                         2 (5.7)            0 (0.0)                 2 (10.0)           
   Surgery + radiotherapy                                               1 (2.9)            0 (0.0)                 1 (5.0)            
   Surgery + CCR                                                        7 (20.0)           3 (20.0)                4 (20.0)           
   Induction + CCR                                                      6 (17.1)           3 (20.0)                3 (15.0)           
   Surgery + induction + CCR                                            12 (34.3)          6 (40.0)                6 (30.0)           
   CCR only                                                             6 (17.1)           3 (20.0)                3 (15.0)           
   Other                                                                1 (2.9)            0 (0.0)                 1 (5.0)            

Abbreviations: CCR, concurrent chemo radiation; IQR, interquartile range.

N = 34, Control = 19.

Feasibility {#section13-1534735417753540}
-----------

### Recruitment {#section14-1534735417753540}

Seventy-three individuals were screened, of whom 40 were eligible. Eleven were ineligible due to recurrence of disease (n = 5), unstable medical condition (n = 2), had not completed physical therapy (n = 2), practiced yoga within the past 6 months (n = 1), and \<3 months posttreatment (n = 1). Twenty-two were not interested because of work obligations (n = 4), illness (n = 3), distance to site (n = 7), time commitment (n = 4), and no stated reason (n = 4) ([Figure 1](#fig1-1534735417753540){ref-type="fig"}).

![Screening, enrollment, and withdrawal.](10.1177_1534735417753540-fig1){#fig1-1534735417753540}

Forty HNC survivors signed consent, enrolled and were randomized to the study. Five intervention patients withdrew early: returned to work (n = 2), disease recurrence (n = 1), and developed nonstudy-related unstable medical conditions (n = 2) ([Figure 1](#fig1-1534735417753540){ref-type="fig"}). There were no statistically significant differences in demographic and disease/treatment characteristics between withdrawals and the remainder of the sample (*P* \> .05). Three enrolled patients required financial assistance with transportation. All wait-listed participants began yoga at the conclusion of their wait-list period.

### Patient Adherence (Intervention Group Only) {#section15-1534735417753540}

Adherence to the on-site, supervised and home sessions practice was excellent as noted in [Table 2](#table2-1534735417753540){ref-type="table"}. It appeared that the perceived benefits of the practice were not gender specific. One of the male patients summarized his perceptions as, "I used to laugh when someone even mentioned yoga. That happens no longer . . . Yoga has given me much needed positive reinforcement both mentally and physically."

###### 

Patient Adherence to Supervised and Home Sessions Protocol (Intervention Group Only).

![](10.1177_1534735417753540-table2)

                                                                               n    Median   Interquartile Range   Minimim   Maximum
  ---------------------------------------------------------------------------- ---- -------- --------------------- --------- ---------
  Supervised sessions^[a](#table-fn3-1534735417753540){ref-type="table-fn"}^                                                 
   Number expected                                                             19   20.0     20-20                 3         20
   Number documented                                                           19   19.0     15-20                 3         20
   Percent compliance per participant                                          19   100.0    85-100                44.4      100.0
  Home sessions^[b](#table-fn4-1534735417753540){ref-type="table-fn"}^                                                       
   Number expected                                                             16   36.0     36-36                 11        36
   Number documented                                                           16   35.0     31-36                 5         41
   Percent compliance per participant                                          16   97.2     87-100                45.5      100.0

Nineteen participants received some yoga; 1 participant discontinued prior to starting yoga.

Sixteen intervention participants returned their home practice diaries.

### Fidelity {#section16-1534735417753540}

The principal investigator met with the external consultants and then separately with the yoga instructor to discuss findings and review videos. The external yoga consultants summarized fidelity as: Awareness practice was consistent with protocol and excellent breathing techniques were always taught. Posture techniques and practice order were tailored based on patient status. The yoga instructor used touch assistance when required. Relaxation and meditation appeared effective. Nostril breathing was seldom taught due to the short duration of the study; however, it could potentially be incorporated into posture, or alternatively, be removed from the protocol. The yoga instructor was encouraged to be more permissive, more open-ended, and less directive, but patients rated the instructor high.

### Safety {#section17-1534735417753540}

No adverse events or suicidal ideations were identified. Eleven patients were referred to the oncologist based on HADS scores. At baseline, 4 of the 15 participants in the intervention group (27%) and 3 of the 20 in the control group (15%) had a score of 8 or higher on either the anxiety or the depression component of the HADS. Those respective numbers at week 4 were 2 of 15 in the intervention (13%) and 5 of 20 in the control (25%); at week 8, were 1 of 15 in the intervention (7%) and 6 of 20 in the control (30%). Overall, 4 patients in the intervention group accounted for all referrals in that group, and only 1 had a score of 8 or higher at week 8. Seven patients in the wait-list group accounted for all referrals, and 6 continued to have high scores at week 8.

### Participant satisfaction {#section18-1534735417753540}

The median value satisfaction with all aspects of the program was 10.0 (the highest possible value). See summaries in [Table 3](#table3-1534735417753540){ref-type="table"}.

###### 

Intervention Group Participant Satisfaction (N = 15).
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  Program Evaluation                          Median                     Interquartile Range   Minimum        Maximum
  ------------------------------------------- -------------------------- --------------------- -------------- -----------------------
  General satisfaction                        10.0                       10-10                 9              10
  Instruction satisfaction                    10.0                       10-10                 10             10
  Physical progress satisfaction              10.0                       8-10                  7              10
  Emotional progress satisfaction             10.0                       9-10                  7              10
  Mental progress satisfaction                10.0                       9-10                  7              10
  Asanas satisfaction                         10.0                       8-10                  6              10
  Breath work satisfaction                    10.0                       9-10                  8              10
  Meditation/Relaxation satisfaction          10.0                       9-10                  7              10
  Likelihood of continuing yoga               10.0                       10-10                 8              10
  Booklet Evaluation                          Strongly Disagree, n (%)   Not Sure, n (%)       Agree, n (%)   Strongly Agree, n (%)
  Wealth of information                       1 (6.7)                    3 (20.0)              7 (46.7)       4 (26.7)
  Helpful tips                                1 (6.7)                    5 (33.3)              3 (20.0)       6 (40.0)
  Motivation                                  1 (6.7)                    2 (13.3)              3 (20.0)       9 (60.0)
  Good pictures                               1 (6.7)                    4 (26.7)              5 (33.3)       5 (33.3)
  Encouraged to examine status                1 (6.7)                    4 (26.7)              4 (26.7)       6 (40.0)
  Engaging, appealing                         1 (6.7)                    4 (26.7)              6 (40.0)       4 (26.7)
  Easy to read, understand                    1 (6.7)                    3 (20.0)              7 (46.7)       4 (26.7)
                                              Median                     Interquartile Range   Minimum        Maximum
  Booklet time in minutes                     30.0                       15-130                3              420
  Practice Log Evaluation                     Disagree, n (%)            Not Sure, n (%)       Agree, n (%)   Strongly Agree, n (%)
  Self-explanatory                            4 (26.7)                   2 (13.3)              6 (40.0)       3 (20.0)
  Easy to complete                            0 (0.0)                    1 (6.7)               8 (53.3)       6 (40.0)
  Didn't take too much time                   0 (0.0)                    0 (0.0)               7 (46.7)       8 (53.3)
  Helped focus                                0 (0.0)                    4 (26.7)              4 (26.7)       7 (46.7)
  Helped see progress                         0 (0.0)                    4 (26.7)              7 (46.7)       4 (26.7)
  Worth my time                               0 (0.0)                    3 (20.0)              4 (26.7)       8 (53.3)
  Comment section helpful                     1 (6.7)                    3 (20.0)              5 (33.3)       6 (40.0)
  Log reflects practice                       0 (0.0)                    4 (26.7)              5 (33.3)       6 (40.0)
                                              Median                     Interquartile Range   Minimum        Maximum
  Time to complete log each time in minutes   10.0                       5-20                  5              30

### Limitations and Modifications {#section19-1534735417753540}

The majority of patients demonstrated MSI that limited movement to the extent that modifications in the core poses were needed. These will be detailed in a separate manuscript.

Efficacy {#section20-1534735417753540}
--------

### Jaw, Shoulder Cervical Range of Motion, and Posture {#section21-1534735417753540}

The most consistent effects were observed in the shoulder region for abduction and external rotation on the right side ([Table 4](#table4-1534735417753540){ref-type="table"}). The statistically significant effects (effect sizes Cohen's *d* = 0.57-0.86) were those of the intervention group demonstrating generally improving ROM while the control group remained stable or decreased in ROM. No statistically significant effects on jaw (Cohen's *d* = 0.20-0.45) or cervical (Cohen's *d* = 0.39) ROM were observed (*P* \> .05). However, baseline dysfunction was low. No significant changes in posture were detected.

###### 

Selected Shoulder Range of Motion Summaries (N = 35; Intervention n = 15, Control n = 20).^[a](#table-fn5-1534735417753540){ref-type="table-fn"}^
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                                                                                            Baseline                                                                           4 Weeks             8 Weeks
  ----------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------- ------------------- -------------------
  Passive abduction, right^[b](#table-fn6-1534735417753540){ref-type="table-fn"}^           (Arm to side, palm up, moving arm away from body toward head as far as possible)                       
   Intervention                                                                             141.0 \[127-155\]                                                                  145.0 \[138-152\]   154.5 \[143-160\]
   Control                                                                                  144.5 \[138-161\]                                                                  140.0 \[132-163\]   135.0 \[124-158\]
  Passive abduction, left                                                                   (Arm to side, palm up, moving arm away from body toward head as far as possible)                       
   Intervention                                                                             136.5 \[131-155\]                                                                  149.0 \[139-163\]   146.5 \[140-162\]
   Control                                                                                  130.5 \[122-156\]                                                                  135.0 \[114-150\]   133.5 \[116-150\]
  Passive external rotation, right^[b](#table-fn6-1534735417753540){ref-type="table-fn"}^   (Arm straight out, bent at elbow with hand up, moving hand back toward head)                           
   Intervention                                                                             68.5 \[63-79\]                                                                     74.0 \[68-84\]      79.0 \[70-82\]
   Control                                                                                  80.5 \[69-87\]                                                                     78.8 \[71-87\]      76.3 \[70-86\]
  Passive external rotation, left                                                           (Arm straight out, bent at elbow with hand up, moving hand back toward head)                           
   Intervention                                                                             69.5 \[60-77\]                                                                     71.0 \[68-78\]      72.0 \[67-80\]
   Control                                                                                  71.3 \[54-84\]                                                                     68.3 \[56-75\]      71.3 \[60-77\]
  Active abduction, right^[b](#table-fn6-1534735417753540){ref-type="table-fn"}^            (Arm to side, palm up, moving arm away from body toward head as far as possible)                       
   Intervention                                                                             140.0 \[127-148\]                                                                  149.0 \[137-160\]   152.5 \[141-162\]
   Control                                                                                  146.0 \[139-162\]                                                                  140.5 \[131-157\]   139.0 \[124-158\]
  Active abduction, left^[b](#table-fn6-1534735417753540){ref-type="table-fn"}^             (Arm to side, palm up, moving arm away from body toward head as far as possible)                       
   Intervention                                                                             139.0 \[126-151\]                                                                  143.5 \[133-157\]   147.5 \[142-162\]
   Control                                                                                  140.0 \[118-152\]                                                                  139.5 \[118-148\]   132.0 \[123-148\]
  Active external rotation, right^[b](#table-fn6-1534735417753540){ref-type="table-fn"}^    (Arm straight out, bent at elbow with hand up, moving hand back toward head)                           
   Intervention                                                                             72.5 \[64-78\]                                                                     76.0 \[69-87\]      80.0 \[72-84\]
   Control                                                                                  79.0 \[74-89\]                                                                     77.5 \[73-86\]      77.0 \[70-85\]
  Active external rotation, Left                                                            (Arm straight out, bent at elbow with hand up, moving hand back toward head)                           
   Intervention                                                                             71.0 \[60-74\]                                                                     71.0 \[62-78\]      72.0 \[63-78\]
   Control                                                                                  71.5 \[50-84\]                                                                     66.5 \[56-77\]      69.8 \[63-76\]

Values are given as median \[interquartile range\].

Statistically significant (*P* \< .05) differences in the patterns of change in the intervention group compared with that in the control group.

### Symptoms {#section22-1534735417753540}

There were statistically significant differences between the study groups in patterns of change in pain (VHNSS General Pain, *P* \< 0.001, effect size Cohen's *d* = 0.90) and pain interference with activities of daily living (BPI Interference, *P* = .005, effect size Cohen's *d* = 0.67). The VHNSS General Pain levels decreased for the intervention group, but increased over the same time period for the controls ([Figure 2](#fig2-1534735417753540){ref-type="fig"}). Median BPI Interference scores were variable and low for both groups. Intervention group variability decreased. Those participants reporting higher levels of interference at baseline tended to demonstrate a decrease in those levels over the course of the study. The opposite pattern was observed for the participants in the control group.

![Summaries of self-reports of pain (VHNSS General Pain), interference from pain (BPI-SF), and anxiety over the study period (HADS) (N = 35; Intervention n = 15, Control n = 20). BPI-SF, Brief Pain Inventory--Short Form; HADS, Hospital Anxiety and Depression Scale; VHNSS, Vanderbilt Head and Neck Symptom Survey.\
All demonstrated statistically significant (*P* \< .05) differences in the patterns of change in the intervention group compared with that in the control group.](10.1177_1534735417753540-fig2){#fig2-1534735417753540}

A statistically significant interaction effect of the yoga intervention was observed for the HADS anxiety scores (*P* = .015, effect size Cohen's *d* = 0.59) but not the depression scores (*P* = .290, effect size Cohen's *d* = 0.31). The intervention participants reported higher anxiety scores at baseline, decreased at 4 weeks and, increased again at 8 weeks. Participants in the control group tended to follow an opposite pattern in that their scores were lower than the intervention group at baseline, increased at 4 weeks, and reduced to baseline levels at 8 weeks ([Figure 2](#fig2-1534735417753540){ref-type="fig"}).

### Body Image {#section23-1534735417753540}

No statistically significant effects on body image were observed in this study (*P* = .647, effect size Cohen's *d* = 0.18).

Discussion {#section24-1534735417753540}
==========

Tailored yoga appears to be safe and feasible in the posttreatment HNC population. No adverse events occurred. Recruitment rates were high as was adherence with guided sessions and home practice. Participants expressed high levels of satisfaction with the yoga instruction and study related tools. Preliminary data indicated that yoga may improve mood, symptom burden, and shoulder function.

Recruitment of HNC survivors to a yoga study was a concern. This population is predominantly male, generally older, and often plagued by late effects that might prove to be barriers to study participation (eg, tracheostomy tubes, feeding tubes). When this study commenced, the majority of yoga studies in the oncology population had been conducted in female survivors of breast cancer.^[@bibr24-1534735417753540],[@bibr25-1534735417753540]^ No known studies had been reported in survivors of HNC. Our study demonstrated that men were willing to participate and were adherent to an intensive yoga program that required both frequent one-on-one guided sessions and daily home practice. However, patients indicated that the duration of the supervised and daily home practice was burdensome. Shorter supervised and tailored home practice should be considered in future studies.

Tracheostomies and feeding tubes presented safety concerns. As such, we incorporated a number of safety measures. The yoga instructor had 500 hours of advanced training in therapeutic aspects of yoga in cancer and chronic illness and spent a year-long preceptorship in the HNC clinic prior to study initiation in order to gain insight into the issues facing this population. Participant's physical and emotional limitations were thoroughly assessed. One-on-one instruction was given to ensure proper alignment and timely modifications. A registered nurse was on-site during yoga sessions. Although the sample was small, the findings suggested that with modifications, patients with implanted devices can safely participate in a tailored yoga program. Furthermore, issues such as xerostomia did not impair practice. Few community instructors have the skill sets or training to deal with this complex patient population. Ensuring adequate training of yoga instructors in order to maintain safety and efficacy is likely to be a challenge, but possible.

Consistent with studies conducted in other cancer populations,^[@bibr26-1534735417753540],[@bibr30-1534735417753540],[@bibr50-1534735417753540][@bibr51-1534735417753540]-[@bibr52-1534735417753540]^ we observed improvement in the region of function we anticipated to be most impacted by yoga practice, shoulder range of motion. Lack of measured change in posture may indicate the need for an alternative measurement method. Pain also demonstrated increased improvement in the practice group compared with the control group. Reduced anxiety in the practice group was noted during the 4 weeks when participants underwent 3 supervised sessions a week. It returned to near baseline levels when supervised sessions were reduced. Thus, 3 supervised yoga sessions a week appear to be more effective in decreasing anxiety than 2 sessions per week.

This was a feasibility study; findings should be considered in light of its limitations. The convenience sample may have resulted in selection bias, as participants who agreed to participate may not have been representative of the entire HNC population. A small sample size, only 8 weeks of yoga, and no follow-up after yoga completion should also be considered. Findings from this pilot study may not generalize to other populations. A larger dose of yoga may have yielded better outcomes; however, patients did not desire a more extensive program. The lack of longer term follow-up leaves unanswered questions regarding the uptake of yoga into the daily lives of the participants and fails to capture long-term outcomes. Many of these limitations can be addressed in a larger study that follows participants for an extended period of time. These limitations are also somewhat offset by strengths of the study that include participation by both genders, strict fidelity oversight, and high patient satisfaction.

Conclusion {#section25-1534735417753540}
==========

A tailored yoga program administered by a trained instructor is safe and feasible for HNC survivors. Patient demographics did not limit recruitment. Men and women were eager to participate due to bothersome late effects from their cancer treatment. Some of the late effects such as; mood, symptom burden, and shoulder function improved through the use of yoga. Significant limitations in movement requiring modifications in poses were found. Preliminary efficacy data support further investigation of yoga in this and other chronically ill populations.
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